about
Visceral and bone metastases of a WHO grade 2 meningioma: A case report and review of the literature.Implementing radiotherapy in Africa: Focus on the needs in Rwanda.[Cognitive evaluation during brain radiotherapy in adults: a simple assessment is possible].[Radiotherapy for brain tumors: which margins should we apply?].[Radiobiology of ablative dose in stereotactic irradiation: data update].[Stereotactic radiotherapy in brain metastases].[Evolution of the management of pediatric and adult medulloblastoma].[Imaging methods used in the differential diagnosis between brain tumour relapse and radiation necrosis after stereotactic radiosurgery of brain metastases: Literature review].Proton therapy for tumors of the base of the skull.Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.3D radiation therapy boost improves the outcome of whole brain radiation therapy treated RPA II patients with one or two brain metastases.Comparison of the dosimetries of 3-dimensions Radiotherapy (3D-RT) with linear accelerator and intensity modulated radiotherapy (IMRT) with helical tomotherapy in children irradiated for neuroblastoma.Early evaluation predicts pain relief of irradiated bone metastases: a single-center prospective study.Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.Superior sulcus non small cell lung carcinoma: retrospective analysis of 42 patientsGene expression mapping of histone deacetylases and co-factors, and correlation with survival time and 1H-HRMAS metabolomic profile in human gliomasThree-dimensional cell culture: a breakthrough in vivo.Tenascin-C: Exploitation and collateral damage in cancer managementEpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients.Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients.Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomasLong-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort.Secondary school students' knowledge of physical therapy: the trinidadian scenario.Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.An institutional retrospective analysis of 93 patients with brain metastases from breast cancer: treatment outcomes, diagnosis-specific prognostic factors.Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy.Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation.Cognitive outcome after radiotherapy in brain tumor.Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancers.Stereotactic radiation therapy of brain metastases from colorectal cancer: A single institution cohort.Superior sulcus non-small cell lung carcinoma: A comparison of IMRT and 3D-RT dosimetry.Impact of EGFR mutations and KRAS amino acid substitution on the response to radiotherapy for brain metastasis of non-small-cell lung cancer.Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture.The mTOR inhibitor RAD001 augments radiation-induced growth inhibition in a hepatocellular carcinoma cell line by increasing autophagy.Time interval between surgery and start of adjuvant radiotherapy in patients with soft tissue sarcoma: A retrospective analysis of 1131 cases from the French Sarcoma Group.Cost Analysis of Complex Radiation Therapy for Patients With Head and Neck Cancer.[Risk of radionecrosis after hypofractionated stereotactic radiotherapy targeting the postoperative resection cavity of brain metastases].Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes.A concurrent ultra-fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma.Toxicity and efficacy of cetuximab associated with several modalities of IMRT for locally advanced head and neck cancer.
P50
Q30253086-DA30A260-B0E6-4D4B-BB8C-5C69C933F6C7Q30276887-BAFF1B2D-1005-481C-BCA0-7563B2B1B7F7Q30665164-0E93FC0E-4B99-4E0C-A4F3-028305EDAD17Q30665406-A13408F5-28E8-42B7-9138-E20943DB33DDQ30826735-688C5CB4-8764-4948-93E8-A094C3755F5CQ30886926-24438428-5B64-4E27-B584-AF62D92B6201Q30978499-09E29D47-1D67-4AAD-9FD6-A6A9E145D8AFQ31172433-AC71AC7C-D103-4590-A1AA-AF33E9ED2C18Q33276183-4C7BEB79-A353-4827-B4B9-5F8DB5C90170Q33394021-EAFD5853-C5FE-45B6-B307-4C9AA6287A8AQ33755603-76CDDFF7-9FC7-40E6-AA32-A8671848D913Q34319964-9B25C05A-E435-47F2-9A4D-02193BA1B855Q34621562-119B1338-4A53-4498-8BFD-64F34B5FD73CQ34666897-46B6B3B5-06D1-4C3A-A2F1-4C5623C80EC5Q34720546-B38BD1E1-7868-4644-AB44-ED52546FC924Q35199111-6BBEA97B-FF0C-4008-9A3C-2FD9BD3E839AQ35381163-F116DF1E-1503-4858-BE8C-F691D1D622D1Q35577959-D2969C43-4C22-45D9-B21F-BA1AF4C2ED4FQ35873287-13F6F0B4-1B42-4F4D-8E04-3A330E42E85AQ35899517-DEE1E3FB-6C51-44D3-B415-D85C572D8C14Q36196936-729131D2-2E49-437E-B7BF-D2AEF4D64EF2Q36250744-1F679EF3-3C84-4AAF-B3BB-3D07F6903671Q36306400-43E218CC-C269-4A23-B46C-414FE6AF4B41Q36437589-33A03164-31E1-4D7B-862A-75F3458006F2Q36538454-0674678E-145D-4BA5-AB8B-A752799C2C40Q37226536-4E81F412-541E-4220-A7C5-57DB6F08AC34Q37319790-3B928DC0-C516-4865-B42D-2AF2138F513DQ38587107-CEC9383C-D6DF-412B-AEC0-903EDD0E007FQ38781721-21821D4F-FAF4-4EC5-AF4E-4729B396D8C6Q38788829-07A66F69-A37D-463A-B869-1C1A115F9EF3Q38834703-4F0F5DBA-0B3F-4BEE-986D-E72ADD735CB9Q38937520-F766117C-3389-4089-845B-22195A259C71Q38942623-C7667653-707D-4726-A9A5-09B46E441F20Q39296881-9620EBC2-D69F-4A19-9283-D517C3B14E56Q39748359-1B5B5BBF-7424-401D-8096-DD826D57249CQ39807836-79954ED3-B25F-4870-A880-96D265F2EBC9Q40183049-25121FC1-FFC5-4560-A778-DCE405F03CEBQ40303833-FC2EB588-D5B1-4D57-BF9C-FFE2C3A0DFA2Q40392229-115FA8D7-7438-4AF3-94C8-381CC74AF75EQ40681249-009EE594-2C70-46E1-8BF3-BE7A102EB058
P50
description
investigador
@es
researcher
@en
name
Georges Noel
@en
type
label
Georges Noel
@en
prefLabel
Georges Noel
@en
P31
P496
0000-0003-4952-5572